Quick Answer
InspireMD, Inc. reported Total Revenue of $8.98 million for fiscal year 2025.
InspireMD, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $8.98M +28.1% |
$7.01M +13.0% |
$6.21M +20.0% |
$5.17M +15.0% |
$4.50M +80.9% |
$2.48M -33.2% |
| Revenue (ASC 606) | $8.98M +28.1% |
$7.01M +13.0% |
$6.21M +20.0% |
$5.17M +15.0% |
$4.50M +80.9% |
$2.48M -33.2% |
| Net Income | -$48.79M -52.4% |
-$32.01M -60.7% |
-$19.92M -7.7% |
-$18.49M -24.0% |
-$14.92M -41.5% |
-$10.54M -5.0% |
| Diluted EPS | -$0.76 +0.0% |
-$0.76 +7.3% |
-$0.82 +65.1% |
-$2.35 | — | — |
| Total Assets | $69.40M +48.3% |
$46.81M -1.8% |
$47.64M +93.3% |
$24.65M -37.9% |
$39.71M +123.4% |
$17.78M +79.9% |
| Cash and Equivalents | $8.94M -52.7% |
$18.92M +96.2% |
$9.64M +108.1% |
$4.63M -61.4% |
$12.00M -5.1% |
$12.64M +129.3% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $55.20M +53.0% |
$36.09M -8.6% |
$39.50M +127.1% |
$17.39M -48.1% |
$33.53M +175.7% |
$12.16M +126.0% |
| R&D Expense | $15.00M +10.0% |
$13.63M +70.8% |
$7.98M +2.2% |
$7.81M +51.4% |
$5.16M +131.0% |
$2.23M -24.4% |
| Operating Income | -$49.61M -48.1% |
-$33.50M -58.5% |
-$21.14M -13.0% |
-$18.71M -27.2% |
-$14.72M -41.8% |
-$10.38M -5.7% |
| Gross Profit | $2.65M +75.9% |
$1.51M -16.7% |
$1.81M +61.8% |
$1.12M +48.1% |
$754.0K +808.4% |
$83.0K -89.0% |
| Shares Outstanding | 43.53M +63.6% |
26.61M +21.8% |
21.84M +162.2% |
8.33M +0.4% |
8.30M +152.6% |
3.28M -16.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $2.52M | +39.4% | +41.9% |
| Revenue (ASC 606) | September 30, 2025 | $2.52M | +39.4% | +41.9% |
| Net Income | September 30, 2025 | -$12.71M | -61.1% | +3.4% |
| Diluted EPS | September 30, 2025 | -$0.17 | -6.3% | +34.6% |
| Total Assets | September 30, 2025 | $78.47M | +55.4% | +135.4% |
| Cash and Equivalents | September 30, 2025 | $63.40M | +300.8% | +450.9% |
| Long-Term Debt | December 31, 2015 | $1.10M | -78.4% | -48.8% |
| Stockholders Equity | September 30, 2025 | $64.11M | +55.0% | +216.7% |
| R&D Expense | September 30, 2025 | $3.63M | -7.2% | -5.2% |
| Operating Income | September 30, 2025 | -$13.05M | -54.2% | -0.2% |
| Gross Profit | September 30, 2025 | $864.0K | +108.7% | +176.0% |
| Shares Outstanding | September 30, 2025 | 41.92M | +63.0% | +28.8% |
- InspireMD, Inc. reported Total Revenue of $8.98 million for fiscal year 2025.
- InspireMD, Inc. showed an increase of +28.1% in Total Revenue compared to the prior fiscal year.
- InspireMD, Inc. reported Revenue (ASC 606) of $8.98 million for fiscal year 2025.
- InspireMD, Inc. showed an increase of +28.1% in Revenue (ASC 606) compared to the prior fiscal year.
- InspireMD, Inc. reported Net Income of -$48.79 million for fiscal year 2025.
- InspireMD, Inc. showed a decrease of -52.4% in Net Income compared to the prior fiscal year.
- InspireMD, Inc. reported Diluted EPS of $0.76 per share (loss) for fiscal year 2025.
- InspireMD, Inc. showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- InspireMD, Inc. reported Total Assets of $69.40 million for fiscal year 2025.
- InspireMD, Inc. showed an increase of +48.3% in Total Assets compared to the prior fiscal year.
- InspireMD, Inc. reported Cash and Equivalents of $8.94 million for fiscal year 2025.
- InspireMD, Inc. showed a decrease of -52.7% in Cash and Equivalents compared to the prior fiscal year.
- InspireMD, Inc. reported Long-Term Debt of $1.10 million for fiscal year 2015.
- InspireMD, Inc. showed a decrease of -78.4% in Long-Term Debt compared to the prior fiscal year.
- InspireMD, Inc. reported Stockholders Equity of $55.20 million for fiscal year 2025.
- InspireMD, Inc. showed an increase of +53.0% in Stockholders Equity compared to the prior fiscal year.
- InspireMD, Inc. reported R&D Expense of $15.00 million for fiscal year 2025.
- InspireMD, Inc. showed an increase of +10.0% in R&D Expense compared to the prior fiscal year.
- InspireMD, Inc. reported Operating Income of -$49.61 million for fiscal year 2025.
- InspireMD, Inc. showed a decrease of -48.1% in Operating Income compared to the prior fiscal year.
- InspireMD, Inc. reported Gross Profit of $2.65 million for fiscal year 2025.
- InspireMD, Inc. showed an increase of +75.9% in Gross Profit compared to the prior fiscal year.
- InspireMD, Inc. reported Shares Outstanding of 43.53 million shares for fiscal year 2025.
- InspireMD, Inc. showed an increase of +63.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: